FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to an agent for intraarticular administration. Agent for intraarticular administration for medical use contains hyaluronic acid or sodium hyaluronate, glucosamine or glucosamine sulphate or glucosamine hydrochloride, 10 mg/ml of vitamin C and a zinc salt. What is also disclosed is the use of the agent for treating a certain group of diseases and conditions and the use of vitamin C for preparing the agent for intraarticular administration.
EFFECT: disclosed is a combined agent for intraarticular administration.
16 cl, 3 ex
Authors
Dates
2020-11-27—Published
2017-04-24—Filed